The present invention relates to the
pharmaceutical technology.
Keratin CF2, methods for producing the same, pharmaceutical compositions containing the same and the use thereof are disclosed, and the present invention particularly relates to
keratin CF2,
nucleic acid molecules encoding the
keratin CF2, expression vectors containing the
nucleic acid molecule, host cells containing the
expression vector or in which the
nucleic acid molecule is incorporated into the
genome, methods for producing the
keratin CF2, pharmaceutical compositions containing the keratin CF2, and the use of the keratin CF2, nucleic acid molecules, expression vectors, host cells or pharmaceutical compositions in the manufacture of antipyretics, analgesics, antitussives, expectorants, anticonvulsants, antiepileptics, antihypertensives, anti-inflammatorys or antivirals.